Solid Tumor

Treatment Stage
Protocol Title 
ClinicalTrials.Gov Link
Penn Research Coordinator 
Am I Eligible?
Recurrent ATRN: A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral ATRN-119 in Patients with Advanced Solid Tumors NCT04905914 Andrea Standish, RN Eligibility Criteria
Recurrent A Phase 1/2 Study of CPI-0209 in Patients with Advanced Solid Tumors and Lymphomas NCT04104776 Destany Fields

Eligibility Criteria

Recurrent First-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1047 in subjects with malignant solid tumors NCT05180474 Katie Hayes, RN Eligibility Criteria